Skip Navigation
Skip to contents




20 results

Gynecomastia: A Rare Adverse Effect of Methylphenidate in an Adolescent Boy

Karayagmurlu A, Varli AT, Coskun M

  • Clin Psychopharmacol Neurosci.
  • 2020 May;18(2):337-339.
  • doi: 10.9758/cpn.2020.18.2.337
Gynecomastia is a benign condition developing in association with localized fat deposition and glandular tissue proliferation in the breast in males, and characterized by breast growth. Drug is one of...
Successful Electroconvulsive Therapy for a 74-year-old Female with Major Depressive Disorder and Tardive Tremor: A Case Report and Literature Review

Yeh JY, Chiu NM, Chang YY, Lin PY, Lee Y

  • Clin Psychopharmacol Neurosci.
  • 2020 May;18(2):331-336.
  • doi: 10.9758/cpn.2020.18.2.331
Tardive tremor is an infrequently form of tardive syndrome that is developed from prolonged treatment with dopamine receptor blocking agents. This condition presents as a prominent tremor that may cause...
Methylphenidate-induced Exacerbation of Chorea in a Child Resolved with Switching to Atomoxetine

Ekinci O, Yaşöz C, Baş SA, Ekinci N, Doğan

  • Clin Psychopharmacol Neurosci.
  • 2020 May;18(2):327-330.
  • doi: 10.9758/cpn.2020.18.2.327
Choreiform movements have been reported with stimulant medications, especially in adults. There is only limited evidence on the management of such reactions in children with attention deficit hyperactivity disorder. Hereby,...
Risk of Neuroleptic Malignant Syndrome with Vesicular Monoamine Transporter Inhibitors

Caroff SN

  • Clin Psychopharmacol Neurosci.
  • 2020 May;18(2):322-326.
  • doi: 10.9758/cpn.2020.18.2.322
Objective: Vesicular monoamine transporter-2 (VMAT2) inhibitors have been proven to be effective for the treatment of tardive dyskinesia and their use is likely to increase. The evidence base of published...
Higher Rightward Laterality of the Hippocampal Tail and Its Association with Early Trauma in Panic Disorder

Lee J, Song Y, Won E, Bang M, Lee SH

  • Clin Psychopharmacol Neurosci.
  • 2020 May;18(2):311-321.
  • doi: 10.9758/cpn.2020.18.2.311
Objective: Early trauma (ET) is widely recognized as a contributing factor to the development of panic disorder (PD) in patients. However, there is a dearth of research on the specific...
Effects of Paliperidone Palmitate on Healthcare Utilization and Costs for Patients with Schizophrenia: A Claim-based Mirror-image Study in South Korea

Lee D, Lee BC, Choi SH, Kang DH, Jon DI, Jung MH

  • Clin Psychopharmacol Neurosci.
  • 2020 May;18(2):303-310.
  • doi: 10.9758/cpn.2020.18.2.303
Objective: Long-acting injectable (LAI) antipsychotics, such as paliperidone palmitate (PP), are known to improve treatment adherence in patients with schizophrenia, which can lead to reductions in relapse and hospitalization rates....
Baclofen-induced Changes in the Resting Brain Modulate Smoking Cue Reactivity: A Double-blind Placebo-controlled Functional Magnetic Resonance Imaging Study in Cigarette Smokers

Ketcherside A, Jagannathan K, Dolui S, Hager N, Spilka N, Nutor C, Rao H, Franklin T, Wetherill R

  • Clin Psychopharmacol Neurosci.
  • 2020 May;18(2):289-302.
  • doi: 10.9758/cpn.2020.18.2.289
Objective: Smoking cue-(SC) elicited craving can lead to relapse in SC-vulnerable individuals. Thus, identifying treatments that target SC-elicited craving is a top research priority. Reduced drug cue neural activity is...
Higher Prevalence of Metabolic Syndrome in Child-adolescent Patients with Bipolar Disorder

Mohite S, Wu H, Sharma S, Lavagnino L, Zeni CP, Currie TT, Soares JC, Pigott TA

  • Clin Psychopharmacol Neurosci.
  • 2020 May;18(2):279-288.
  • doi: 10.9758/cpn.2020.18.2.279
Objective: Previous studies have indicated a convergent and bidirectional relationship between metabolic syndrome (MetS) and bipolar disorder (BD). As most of these studies focused mainly on adults diagnosed with BD,...
High Serum Levels of Serum 100 Beta Protein, Neuron-specific Enolase, Tau, Active Caspase-3, M30 and M65 in Children with Autism Spectrum Disorders

Ayaydın H, Kirmit A, Çelik H, Akaltun , Koyuncu , Ulgar

  • Clin Psychopharmacol Neurosci.
  • 2020 May;18(2):270-278.
  • doi: 10.9758/cpn.2020.18.2.270
Objective: The purpose of this study was therefore to investigate whether neuronal, axonal, and glial cell markers (Neuron-specific enolase [NSE], tau, serum 100 beta protein [S100B], respectively) and apoptosis markers...
Associations between Exposure to Bisphenol A and Behavioral and Cognitive Function in Children with Attention-deficit/Hyperactivity Disorder: A Case-control Study

Yoo SJ, Joo H, Kim D, Lim MH, Kim E, Ha M, Kwon HJ, Paik KC, Kim KM

  • Clin Psychopharmacol Neurosci.
  • 2020 May;18(2):261-269.
  • doi: 10.9758/cpn.2020.18.2.261
Objective: Bisphenol A (BPA) is a widely produced synthetic chemical used to manufacture polycarbonate plastics and epoxy resins. We aimed to investigate the association between exposure to BPA and behavioral...
Associations between the Mismatch-negativity Potential and Symptom Severity in Medication-naïve Children and Adolescents with Symptoms of Attention Deficit/hyperactivity Disorder

Lee YJ, Jeong MY, Kim JH, Kim JS

  • Clin Psychopharmacol Neurosci.
  • 2020 May;18(2):249-260.
  • doi: 10.9758/cpn.2020.18.2.249
Objective: The mismatch negativity (MMN) event-related potential is an index of the pre-attentive stage of neural auditory information processing and an electrophysiological signal indicative of the integrity of auditory information...
Magnesium Increases the Protective Effect of Citicoline on Aluminum Chloride-induced Cognitive Impairment

Hosseini-Sharifabad A, Rabbani M, Seyed-Yousefi Y, Safavi M

  • Clin Psychopharmacol Neurosci.
  • 2020 May;18(2):241-248.
  • doi: 10.9758/cpn.2020.18.2.241
Objective: Alzheimer’s disease is a popular neurodegenerative disorder which is growing in the elderly people. Exposure to environmental pollutant like aluminum could trigger or accelerate its involved mechanisms like tau...
ZNF804A Gene Variants Have a Cross-diagnostic Influence on Psychosis and Treatment Improvement in Mood Disorders

Calabrò M, Mandelli L, Crisafulli C, Nicola MD, Colombo R, Janiri L, Lee SJ, Jun TY, Wang SM, Masand PS, Patkar AA, Han C, Pae CU, Serretti A

  • Clin Psychopharmacol Neurosci.
  • 2020 May;18(2):231-240.
  • doi: 10.9758/cpn.2020.18.2.231
Objective: Genetic variations in the gene encoding zinc finger protein 804A gene (ZNF804A) have been associated with major depression and bipolar disorder. In this work we focused on the potential...
The Neurochemical Effects of Prazosin Treatment on Fear Circuitry in a Rat Traumatic Stress Model

Ketenci S, Acet NG, Sarıdoğan GE, Aydın B, Cabadak H, Gören MZ

  • Clin Psychopharmacol Neurosci.
  • 2020 May;18(2):219-230.
  • doi: 10.9758/cpn.2020.18.2.219
Objective: The timing of administration of pharmacologic agents is crucial in traumatic stress since they can either potentiate the original fear memory or may cause fear extinction depending on the...
Lithium Stabilizes the Mood of Bipolar Patients by Depolarizing the Neuronal Membrane Via Quantum Tunneling through the Sodium Channels

Qaswal AB

  • Clin Psychopharmacol Neurosci.
  • 2020 May;18(2):214-218.
  • doi: 10.9758/cpn.2020.18.2.214
Objective: Lithium is used as first line in treating bipolar patients to stabilize their mood. However, the exact mechanism of lithium is not yet established. One of the proposed mechanisms...
Vitamin D Supplementation is Beneficial for Children with Autism Spectrum Disorder: A Meta-analysis

Song L, Luo X, Jiang Q, Chen Z, Zhou L, Wang D, Chen A

  • Clin Psychopharmacol Neurosci.
  • 2020 May;18(2):203-213.
  • doi: 10.9758/cpn.2020.18.2.203
Objective: We conducted a meta-analysis of randomized controlled trials to explore whether vitamin D supplementation is beneficial for symptom improvement in children with autism spectrum disorder. Methods: We systematically searched the...
Contemporary Pharmacotherapeutics and the Management of Aggressive Behavior in an Adolescent Animal Model of Maladaptive Aggression

Einberger C, Puckett A, Ricci L, Melloni Jr. R

  • Clin Psychopharmacol Neurosci.
  • 2020 May;18(2):188-202.
  • doi: 10.9758/cpn.2020.18.2.188
Objective: Antipsychotic and anticonvulsant medications are increasingly being used as pharmacotherapeutic treatments for maladaptive aggression in youth, yet no information is available regarding whether these drugs exhibit aggressionspecific suppression in...
The Role of the SLC Transporters Protein in the Neurodegenerative Disorders

Aykaç A, Şehirli A

  • Clin Psychopharmacol Neurosci.
  • 2020 May;18(2):174-187.
  • doi: 10.9758/cpn.2020.18.2.174
The solute carrier (SLC) superfamily is one of the major sub-groups of membrane proteins in mammalian cells. The solute carrier proteins include more than 400 different membrane-spanning solute carriers organized...
Taking a Responsibility for Future Progression of Clinical Psychopharmacology and Neuroscience

Pae CU

  • Clin Psychopharmacol Neurosci.
  • 2020 May;18(2):172-173.
  • doi: 10.9758/cpn.2020.18.2.172
Editor’s Farewell

Jon DI

  • Clin Psychopharmacol Neurosci.
  • 2020 May;18(2):171.
  • doi: 10.9758/cpn.2020.18.2.171

Go to Top

Copyright © 2020 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: